Gateway 2011: Jost Chemical Co - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Gateway 2011: Jost Chemical Co


Your online Gateway to Jost Chemical Co. in 2011

"Quality Delivered On-Time"

8150 Lackland
St. Louis, MO   63114
Phone: +1.314.428.4300
Fax: +1.314.428.4366
www.jostchemical.com

For over 25 years Jost Chemical Co. has manufactured high purity specialty chemicals for the pharmaceutical, nutritional, food and reagent market. Jost’s St. Louis, MO site, comprised of two manufacturing buildings totaling 190,000 ft2, is FDA registered and operates under ICH Q7 bulk pharmaceutical cGMP’s. Our 250+ high purity chemical salts are manufactured to meet USP/EP/BP/JP/ACS/FCC and multi-compendia requirements and are BSE/TSE free and allergen free. By continually focusing on product quality through controlled validated processes and lot-to-lot product consistency, Jost is able to meet specific product requirements and if required can develop a DMF, ASMF and CEP. Packaging options include fiber drums, poly drums, poly pails, cartons, super sacks, etc. Custom packaging is also available. Please visit Jost’s website at www.jostchemical.com to access information on product specifications, MSDS’s and various product certifications.


Visit our Stand: Number FOD10


We look forward to meeting with you at the 2011 CPhI Exhibition in Frankfurt, Germany to discuss how Jost Chemical can assist in your drug development projects. Please contact Jeff Lenger, Director of Sales and Marketing, to arrange a meeting at CPhI. Jeff can be contacted at jeff.lenger@jostchemical.com

 

Jost Lab

New Products
and Releases
New Whitepapers

Coming soon!

Coming soon!



ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes

Click here